| Name | azd3264 |
|---|---|
| Synonyms |
inhibit,I kappa B kinase,IκB kinase,AZD 3264,AZD-3264,AZD3264,IKK,Inhibitor
3-Thiophenecboxamide, 2-[(aminocbonyl)amino]-5-[4-(3,5-dimethyl-4-isoxazolyl)-2-[(3S)-3-pyrrolidinyloxy]phenyl] (S)-5-(4-(3,5-Dimethylisoxazol-4-yl)-2-(pyrrolidin-3-yloxy)phenyl)-2-ureidothiophene-3-cboxamide AZD3264, 10 mM in DMSO 2-(Carbamoylamino)-5-{4-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(3S)-3-pyrrolidinyloxy]phenyl}-3-thiophenecarboxamide AZD-3264; AZD |
| Description | AZD3264 is a selective IkB-kinase IKK2 inhibitor. |
|---|---|
| Related Catalog | |
| Target |
IKK2 |
| In Vivo | AZD3264 is a selective IkB-kinase IKK2 inhibitor, which is currently in preclinical development for the potential treatment of chronic pulmonary obstructive disorder (COPD) and asthma[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 614.2±55.0 °C at 760 mmHg |
| Molecular Formula | C21H23N5O4S |
| Molecular Weight | 441.503 |
| Flash Point | 325.2±31.5 °C |
| Exact Mass | 441.147064 |
| LogP | 2.08 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.653 |
| Storage condition | -20℃ |